Fullerton NE - Search Results

1

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

Fullerton NE, Boyd M, Ross SC, Pimlott SL, Babich J, Kirk D, Zalutsky MR, Mairs RJ. Fullerton NE, et al. Med Chem. 2005 Nov;1(6):611-8. doi: 10.2174/157340605774598090. Med Chem. 2005. PMID: 16787344

2

Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate.

Fullerton NE, Boyd M, Mairs RJ, Keith WN, Alderwish O, Brown MM, Livingstone A, Kirk D. Fullerton NE, et al. Prostate Cancer Prostatic Dis. 2004;7(4):355-63. doi: 10.1038/sj.pcan.4500760. Prostate Cancer Prostatic Dis. 2004. PMID: 15477875

3

Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.

Fullerton NE, Mairs RJ, Kirk D, Keith WN, Carruthers R, McCluskey AG, Brown M, Wilson L, Boyd M. Fullerton NE, et al. Eur Urol. 2005 Feb;47(2):250-6. doi: 10.1016/j.eururo.2004.09.009. Eur Urol. 2005. PMID: 15661422

4

Gene manipulation to enhance MIBG-targeted radionuclide therapy.

Mairs RJ, Fullerton NE, Cosimo E, Boyd M. Mairs RJ, et al. Among authors: fullerton ne. Nucl Med Biol. 2005 Oct;32(7):749-53. doi: 10.1016/j.nucmedbio.2005.03.011. Nucl Med Biol. 2005. PMID: 16243651 Review.

5

Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.

Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, Mairs RJ. Boyd M, et al. Among authors: fullerton ne. J Nucl Med. 2006 Jun;47(6):1007-15. J Nucl Med. 2006. PMID: 16741311 Free article.

6

Targeted radiotherapy: microgray doses and the bystander effect.

Mairs RJ, Fullerton NE, Zalutsky MR, Boyd M. Mairs RJ, et al. Among authors: fullerton ne. Dose Response. 2007 Apr 20;5(3):204-13. doi: 10.2203/dose-response.07-002.Mairs. Dose Response. 2007. PMID: 18648605 Free PMC article.

7

Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma.

Williamson A, Houston P, Paterson J, Chalmers AJ, McLoone P, Fullerton N, Foo SY, James A, Nowicki S. Williamson A, et al. Neurooncol Adv. 2024 Aug 6;6(1):vdae131. doi: 10.1093/noajnl/vdae131. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39220244 Free PMC article.

8

Modafinil in the rehabilitation of a patient with post-surgical posterior fossa syndrome: a lesson to be learned?

Molinari E, Oto M, Waterston A, Fullerton N. Molinari E, et al. Cerebellum Ataxias. 2019 Aug 15;6:11. doi: 10.1186/s40673-019-0105-6. eCollection 2019. Cerebellum Ataxias. 2019. PMID: 31428435 Free PMC article. Review.

9

Leigh syndrome: an adult presentation of a paediatric disease.

Watson-Fargie T, Marshall V, Fullerton NE, Leach V, Pilz D, Hemingbrough CVY, Hopton S, Taylor RW, Ng YS, Schaefer A, Gorman GS, Farrugia ME. Watson-Fargie T, et al. Among authors: fullerton ne. Pract Neurol. 2024 Jan 23;24(1):45-50. doi: 10.1136/pn-2023-003862. Pract Neurol. 2024. PMID: 37567761

10

Alcohol and the central nervous system.

Wolfe M, Menon A, Oto M, Fullerton NE, Leach JP. Wolfe M, et al. Among authors: fullerton ne. Pract Neurol. 2023 Aug;23(4):273-285. doi: 10.1136/pn-2023-003817. Epub 2023 Jun 16. Pract Neurol. 2023. PMID: 37328277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters